Bentivoglio, Anna Rita
 Distribuzione geografica
Continente #
NA - Nord America 14.909
EU - Europa 10.744
AS - Asia 10.420
SA - Sud America 1.925
Continente sconosciuto - Info sul continente non disponibili 498
AF - Africa 288
OC - Oceania 35
Totale 38.819
Nazione #
US - Stati Uniti d'America 14.487
SG - Singapore 4.438
DE - Germania 3.009
CN - Cina 2.484
IT - Italia 2.034
BR - Brasile 1.542
SE - Svezia 1.370
VN - Vietnam 1.172
FR - Francia 1.071
UA - Ucraina 874
GB - Regno Unito 532
IE - Irlanda 491
IN - India 403
FI - Finlandia 342
HK - Hong Kong 338
ID - Indonesia 306
RU - Federazione Russa 293
JP - Giappone 284
TR - Turchia 202
CA - Canada 201
BD - Bangladesh 177
AR - Argentina 150
NL - Olanda 143
PL - Polonia 130
MX - Messico 114
IQ - Iraq 112
ES - Italia 100
BE - Belgio 76
CI - Costa d'Avorio 70
ZA - Sudafrica 70
KR - Corea 69
AT - Austria 68
PK - Pakistan 58
EC - Ecuador 57
IR - Iran 46
SA - Arabia Saudita 46
VE - Venezuela 42
UZ - Uzbekistan 39
CO - Colombia 36
AU - Australia 31
CL - Cile 29
PH - Filippine 29
CH - Svizzera 27
JO - Giordania 27
MA - Marocco 27
PY - Paraguay 25
CZ - Repubblica Ceca 24
IL - Israele 24
KE - Kenya 24
LT - Lituania 22
AZ - Azerbaigian 19
RO - Romania 19
BO - Bolivia 18
JM - Giamaica 18
KZ - Kazakistan 18
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
EG - Egitto 16
TT - Trinidad e Tobago 15
BG - Bulgaria 14
DZ - Algeria 14
PE - Perù 14
CR - Costa Rica 13
EU - Europa 12
NP - Nepal 12
AL - Albania 11
ET - Etiopia 11
HU - Ungheria 11
PA - Panama 11
UY - Uruguay 11
DK - Danimarca 10
GR - Grecia 10
MY - Malesia 10
OM - Oman 10
SN - Senegal 10
GT - Guatemala 9
LB - Libano 9
NI - Nicaragua 9
PT - Portogallo 9
TH - Thailandia 9
TW - Taiwan 9
EE - Estonia 8
HN - Honduras 8
PS - Palestinian Territory 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
MD - Moldavia 7
LU - Lussemburgo 6
KG - Kirghizistan 5
KW - Kuwait 5
NG - Nigeria 5
NO - Norvegia 5
AM - Armenia 4
BB - Barbados 4
BH - Bahrain 4
GA - Gabon 4
KH - Cambogia 4
NZ - Nuova Zelanda 4
QA - Qatar 4
RS - Serbia 4
Totale 38.264
Città #
Singapore 2.306
Ashburn 1.603
Chandler 1.551
San Jose 1.535
Dublin 481
Jacksonville 461
Beijing 450
Milan 400
Ho Chi Minh City 379
San Mateo 369
Los Angeles 338
New York 324
Rome 323
Hanoi 309
Nanjing 294
Jakarta 280
Ann Arbor 275
Lauterbourg 272
Wilmington 248
Tokyo 244
Hefei 243
Munich 223
Hong Kong 203
Boston 196
Dearborn 188
Dallas 179
Frankfurt am Main 172
The Dalles 153
Woodbridge 153
Houston 149
Lawrence 141
Chicago 139
Nürnberg 137
Moscow 135
São Paulo 131
Cattolica 126
Marseille 119
Izmir 117
Boardman 116
Seattle 115
Redwood City 102
Santa Clara 102
Lancaster 100
Helsinki 97
Warsaw 96
Princeton 95
Nanchang 89
Redmond 89
Fairfield 83
Council Bluffs 81
Figino 79
Buffalo 77
Shenyang 74
Abidjan 70
Atlanta 70
Brussels 69
Da Nang 69
London 67
Norwalk 65
Brooklyn 62
Kent 62
Phoenix 60
Cambridge 59
Hebei 59
Jiaxing 56
Mountain View 55
Rio de Janeiro 55
Hangzhou 54
Orem 54
Pune 54
Tianjin 54
Shanghai 53
Seoul 51
University Park 51
Nuremberg 49
Haiphong 48
Changsha 47
Montreal 47
Bremen 45
Memphis 45
Paris 45
Denver 44
Guangzhou 44
Toronto 44
Kunming 43
St Louis 43
Amsterdam 41
Brasília 41
Chennai 41
Lappeenranta 41
Johannesburg 40
Baghdad 38
Leawood 38
Vienna 38
Naples 37
Turin 35
Zhengzhou 35
Trieste 33
Belo Horizonte 31
Fremont 31
Totale 19.054
Nome #
Frameless stereotaxy in subthalamic deep brain stimulation: 3-year clinical outcome 1.064
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 367
Measuring gait quality in Parkinson’s disease through real-time gait phase recognition 325
What about the caregiver? A journey into Parkinson's disease following the burden tracks 278
The role of small intestinal bacterial overgrowth in Parkinson's disease 257
F057 Affective and cognitive components of theory of mind in Huntington’s disease: yoni task performance in early and mid-disease stages 246
Heart Rate Variability during wake and sleep in Huntington's Disease patients. An observational, cross-sectional, cohort study 238
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 237
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington's and Parkinson's diseases 228
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 223
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 222
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 221
Difference in striatal dopamine transporter availability and psychiatric symptoms in Parkinson's disease subtypes: 123I-FP-CIT SPECT results 221
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 216
Patient's Loss of Empathy Is Associated With Caregiver Burden 213
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 210
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 206
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 203
Assessment of neurological manifestations in hospitalized patients with COVID-19 203
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 201
RAB32 mutation in Parkinson's disease [2] 200
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 196
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 195
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 194
Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement 194
Mutation screening of the DYT6/THAP1 gene in Italy 193
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 192
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 189
Rehabilitation of hypomimia in Parkinson's disease: a feasibility study of two different approaches 189
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 185
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 182
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 181
Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment 176
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 176
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 175
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 174
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 173
Emotional Awareness, Relationship Quality, and Satisfaction in Patients With Parkinson's Disease and Their Spousal Caregivers 173
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 173
Phenotypic characterisation of DYT13 primary torsion distonia. 171
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 171
Prevalence of spinocellulart ataxia type 2 mutation among ittalian Parkinsonian patients 169
Reliability of Clinical Diagnosis of Dystonia 169
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 169
Movement disorders in multiple sclerosis: Causal or coincidental association? 167
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 167
Atrofia multisistemica: correlazioni tra caratteristiche cliniche, prove di reflettività cardiovascolare e reperti di risonanza magnetica 166
Dopaminergic agents and nutritional status in Parkinson's disease 165
New olfactometric findings in Parkinson's disease 162
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 162
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 161
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 161
Ataxia-Telangiectasia Presenting as Tremor-Predominant Syndrome in an Adult Patient without Ataxia and Telangiectasias 160
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 160
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 160
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 158
Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa responsive parkinsonism 158
Clinical and genetic characteristics of late-onset Huntington's disease 158
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 157
Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature 157
Dystonia gravidarum: a new case with a long follow-up 156
Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families 156
Use of ACE-inhibitors and falls in patients with Parkinson's disease 156
Parkinson’s disease and virtual reality rehabilitation: cognitive reserve influences the walking and balance outcome 156
Effect of aging on biomarkers and clinical profile in Parkinson's disease 155
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 155
Transcranial magnetic stimulation predicts functional recovery after botulinum toxin treatment in stroke patients 155
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 155
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 154
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. 153
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 153
Epidemiological, Clinical, and Molecular Study of a Cohort of Italian Parkinson Disease Patients: Association with Glutathione-S-Transferase and DNA Repair Gene Polymorphisms 152
Blepharospasm with non-satisfactory response to treatment: Our experience with IncobotulinumtoxinA 152
Movement disorders following mechanical thrombectomy resulting in ischemic lesions of the basal ganglia: An emerging clinical entity 151
Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview 151
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 151
Punding and computer addiction in Parkinson's disease 150
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 150
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 148
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 148
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 147
Early DEtection of wEaring off in Parkinson disease: the DEEP study 147
Association of metabolic syndrome with falls in patients with Parkinson's disease 147
Clinical differences between botulinum neurotoxin type A and B 147
Analysis of blink rate in patients with blepharospasm 146
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 145
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 145
Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy 145
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 145
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 145
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 144
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis 143
What about the caregiver? A journey into Parkinson’s disease following the burden tracks 143
Botulinum toxin injection for the treatment of chronic anal fissure: uni- and multivariate analysis of the factors that promote healing 143
Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson's disease 142
Cardiac autonomic nervous system evaluation in Parkinson disease and multisystem atrophy 142
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 142
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 141
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease 141
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 141
Totale 18.455
Categoria #
all - tutte 160.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.943 0 215 58 116 110 67 38 313 82 153 327 464
2022/20234.483 523 589 355 602 337 528 238 351 645 90 161 64
2023/20242.319 86 663 77 159 90 307 145 151 34 67 252 288
2024/20254.977 104 171 409 152 383 199 207 254 762 431 1.057 848
2025/202614.060 1.941 420 840 1.412 2.134 684 2.529 887 897 1.183 525 608
2026/20272.386 790 1.596 0 0 0 0 0 0 0 0 0 0
Totale 38.819